These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29544899)

  • 1. Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing.
    Hessel EVS; Staal YCM; Piersma AH
    Toxicol Appl Pharmacol; 2018 Sep; 354():136-152. PubMed ID: 29544899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Developmental neurotoxicity.
    Bal-Price A; Fritsche E
    Toxicol Appl Pharmacol; 2018 Sep; 354():1-2. PubMed ID: 30030094
    [No Abstract]   [Full Text] [Related]  

  • 3. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.
    Vorhees CV; Sprowles JN; Regan SL; Williams MT
    Toxicol Appl Pharmacol; 2018 Sep; 354():176-190. PubMed ID: 29544898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
    Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
    Terron A; Bennekou SH
    Toxicol Appl Pharmacol; 2018 Sep; 354():19-23. PubMed ID: 29454059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J; Settivari R; LeBaron MJ; Marty MS
    Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.
    Schmidt BZ; Lehmann M; Gutbier S; Nembo E; Noel S; Smirnova L; Forsby A; Hescheler J; Avci HX; Hartung T; Leist M; Kobolák J; Dinnyés A
    Arch Toxicol; 2017 Jan; 91(1):1-33. PubMed ID: 27492622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment.
    Harrill JA; Freudenrich T; Wallace K; Ball K; Shafer TJ; Mundy WR
    Toxicol Appl Pharmacol; 2018 Sep; 354():24-39. PubMed ID: 29626487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for Developmental Neurotoxicity at the National Toxicology Program: The Future Is Here.
    Behl M; Ryan K; Hsieh JH; Parham F; Shapiro AJ; Collins BJ; Sipes NS; Birnbaum LS; Bucher JR; Foster PMD; Walker NJ; Paules RS; Tice RR
    Toxicol Sci; 2019 Jan; 167(1):6-14. PubMed ID: 30496580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the Concept for Stem Cell-Based Developmental Neurotoxicity Evaluation.
    Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
    Toxicol Sci; 2018 Sep; 165(1):14-20. PubMed ID: 29982725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M; Willett C; Pistollato F; Bal-Price A
    Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting report: alternatives for developmental neurotoxicity testing.
    Lein P; Locke P; Goldberg A
    Environ Health Perspect; 2007 May; 115(5):764-8. PubMed ID: 17520065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes.
    Crofton K; Fritsche E; Ylikomi T; Bal-Price A
    ALTEX; 2014; 31(2):223-4. PubMed ID: 24794006
    [No Abstract]   [Full Text] [Related]  

  • 16. Rotenone exerts developmental neurotoxicity in a human brain spheroid model.
    Pamies D; Block K; Lau P; Gribaldo L; Pardo CA; Barreras P; Smirnova L; Wiersma D; Zhao L; Harris G; Hartung T; Hogberg HT
    Toxicol Appl Pharmacol; 2018 Sep; 354():101-114. PubMed ID: 29428530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
    Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
    Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systems biology approach to predictive developmental neurotoxicity of a larvicide used in the prevention of Zika virus transmission.
    Audouze K; Taboureau O; Grandjean P
    Toxicol Appl Pharmacol; 2018 Sep; 354():56-63. PubMed ID: 29476864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New animal-free concepts and test methods for developmental toxicity and peripheral neurotoxicity.
    Leist M
    Altern Lab Anim; 2017 Nov; 45(5):253-260. PubMed ID: 29112453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
    Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
    Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.